22
Lopate G., Parks B.J., Goldstein J.M. et al. Polyneuropathies associated with high
titre antisulphatide antibodies: characteristics of patients with and without serum
monoclonal proteins // J. Neurol. Neurosurg. Psychiatry. - 1997. -
Vol. 62, № 6.
- P.
581-585.
Lorusso L., Mikhailova S.V., Capelli E. et al. Immunological aspects of chronic
fatigue syndrome // Autoiimun. Rev.
–
2009.
–
Vol. 8, № 4. –
P. 287-291.
Madrid A., Gil-Peralta A., Gil-
Néс
ig E. et al.
Morvan’ s
fibrillary chorea: remission
after plasmapheresis // J. Neurol. - 1996. -
Vol. 243, № 4.
- P. 350-353.
Maga
ña S.M., Pittock S.J., Lennon V.A. et al.
Neuromyelitis optica IgG serostatus in
fulminant central nervous system inflammatory demyelinating disease // Arch. Neurol.
–
2009.
–
Vol. 66, № 8. –
P. 964-966.
Maga
ñ
a S.M., Keegan B.M., Weinshenker B.G. et al. Beneficial plasma exchange
response in CNS inflammatory demyelination // Arch. Neurol.
–
2011.
–
Vol. 68, № 7. –
P. 870-878.
Majorga C., Luque G., Romero F. et al. Antibodies to commercially available
interferon-beta molecules in multiple sclerosis patients treated with natural interferon-
beta // Int. Arch. Allergy Immunol.
–
1999.
–
Vol. 118, № 2
-4.
–
P. 368-371.
Mastriani J.A., Nixon R., Layzer R. et al. Prion protein conformation in patients with
sporadic fatal insomnia // New Engl. J. Med. - 1999. -
Vol. 340, № 21.
- P. 1630-1638.
McDaneld L.M., Fields J.D., Bourdette D.N., Bhardwaj A. Immunomodulatory
therapies in neurologic critical care // Neurocrit. Care.
–
2010.
–
Vol. 12, № 1. –
P. 132-
143.
Meena A.K., Khadikar S.V., Murthy J.M.K. Teatment guidelines for Guillain-Barr
é
syndrome // Ann. Indian Acad. Neurol.
–
2011.
–
Vol. 14, Suppl. 1.
–
P.S73-S81.
Mirza M.K., Pogoriler J., Paral K. et al. Adjunct therapeutic plasma exchange for
anti-N-methyl-D-aspartate receptor antibody encephalitis: a case report and review of
literature // J. Clin. Apher.
–
2011.
–
Vol. 26, № 6. –
P. 362-365.
Miyamoto K., Kusunoki S. Intermittent plasmapheresis prevents recurrence in
neuromyelitis optica // Ther. Apher. Dial.
–
2009.
–
Vol. 13, № 6. –
P. 505-508.
Moll J.W.B., Hooijkaas H., van Goorbergh B.C.M. et al. Systemic and antineuronal
autoantibodies in patients with paraneoplastic neurological disease // J. Neurol. - 1996. -
Vol. 243, № 1. Р
. 51-56.
Myasthenia Gravis Clinical Group, Gajdos Ph., Chevret S. et al., Clinical trial of
plasma exchenge and high-dose intravenous immunoglobulin im myasthenia gravis.
–
Ann. Neurol.
–
1997.
–
Vol. 35, № 41. –
P. 789-796.
Nachamkin I., Ung H., Moran A.P. et al. Ganglioside GM1 mimicry in
Campilobacter
strains from sporadic infections in the United States // J. Infect. Dis.
–
1999.
–
Vol. 179,
№ 5. –
P. 1183-1189.
23
Nakamura Y., Kawachi Y., Furuta J., Otsuka F. Sewere local skin reactions to
interferon beta-1b in multiple sclerosis-improvement by deep subcutaneous injection //
Eur. J. Dermatol.
–
2008.
–
Vol. 18, № 5. –
P. 579-582.
Netto A.B., Taly A.B., Kulkarni G.B. et al. Mortality in mechanically ventilated
patients of Guillain-Barr
é
syndrome // An. Indian Acad. Neurol.
–
2011.
–
Vol. 14, № 4.
–
P. 262-268.
Nowak R.J. Response of patients with refractory myasthenia gravis to rituximab: a
retrospective study // Ther. Adv. Neurol. Disord.
–
2011.
–
Vol. 4, № 5. –
P. 259-266.
Offen D., Halevi S., Mosberg R. et al. Antibodies from ALS patients inhibit dopamine
release mediated by L-type calcium channels // Neurology. - 1998. -
Vol. 51, № 4.
- P.
1100-1103.
Ohji S., Nomura K. [The indication of steroid therapy and apheresis therapy for
multiple sclerosis] // Nippon. Rinsho.
–
2008.
–
Vol. 66, № 6. –
P. 1127-1132.
Okushin H., Morii K., Uesaka K., Yasa S. Twenty four-week peginterferon plus
ribavirin after interferon-
β
induction for genotype 1b chronic hepatitis C // World J.
Hepatol.
–
2010.
–
Vol. 2, № 6. –
P. 226-232.
Papazian O., Alfonso I. Juvenile myasthenia gravis // Medicina (B Aires).
–
2009.
–
Vol. 69, № 1. –
P. 71-83.
Park Y.-E., Yook J.-W., Kim D.-S. A case of Lewis-Sumner syndrome showing
dramatic improvement after plasma exchange // J. Korean Med. Sci.
–
2010.
–
Vol. 25,
№ 7. –
P. 1101-1104.
Perera N.J., Lewis B., Tran H. et al.
Refsum’s disease
-use of the intestinal lipase
inhibitor, Orlistat, as novel therapeutic approach to a complex disorder // J. Obes.
–
2011.
–
pii: 482021.
Pestronk A., Choki R. Multifocal motor neuropathy. Serum IgM anti-GM1
ganglioside antibodies in most patients detected using covalent lincage of Gm1 to
ELISA plates // Neurology. - 1997. -
Vol. 49, № 5.
- P. 1289-1291.
Pham H.P., Daniel-Johnos J.A., Stotler B.A. et al. Therapeutic plasma exchange for
the treatment of anti-NMDA receptor encephalitis // J. Clin. Apher.
–
2011.
–
Vol. 26, №
6.
–
P. 320-325.
Pittayanon R., Treepraertsuk S., Phanthumchinda K. Plasmapheresis or intravenous
immunoglobulin for myasthenia gravis crisis in King Chulalongkorn Memorial Hospital //
J. Med. Assoc. Thai.
–
2009.
–
Vol. 92, № 4. –
P. 478-482.
Plasma Exchange / Sandoglobulin Gillain-
Barré Syndrome Trial Group.
Randomised trial of plasma exchange, intravenous immunoglobulin, and combined
treatment in Guillain-
Barré syndrome // Lancet.
- 1997. -
Vol. 349, № 9047.
- P. 225-
230.
Plosker D.L. Interferon-
β
-1b: a review of its use in multiple sclerosis // CNS Drugs.
–
2011.
–
Vol. 25, № 1. –
P. 67-88.